🇺🇸 FDA
Patent

US 11918551

Methods of treating seizure disorders and Prader-Willi syndrome

granted A61KA61K31/196A61P

Quick answer

US patent 11918551 (Methods of treating seizure disorders and Prader-Willi syndrome) held by OVID THERAPEUTICS INC. expires Mon Feb 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
OVID THERAPEUTICS INC.
Grant date
Tue Mar 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K31/196, A61P, A61P25/08